Medical Oncology
Dr. Praful Pandey
AIIMS-trained medical oncologist with national rank distinctions, peer-reviewed academic work and a practice built around evidence, clarity and shared decision-making.
MD Medicine
DM Medical Oncology
About
Academic rigour, carried into every treatment decision.
Dr. Praful Pandey completed both MD Medicine and DM Medical Oncology at the All India Institute of Medical Sciences, New Delhi. He is a Consultant Medical Oncologist at Medanta Hospital, Noida, alongside his consultant practice at Praneva.
His work spans solid tumours and haematological malignancies, including chemotherapy, targeted therapy, immunotherapy, supportive care and survivorship. Every recommendation is framed around evidence, anticipated benefit, toxicity and the patient’s priorities.
His academic record includes national entrance ranks, peer-reviewed research, oncology reviews, textbook chapters and multidisciplinary tumour-board experience. At Praneva, that depth is used for one purpose: a plan that can withstand careful questioning.
Not here for cancer care?
Dr. Praful also consults as a general physician — fever, infections, diabetes, blood pressure and thyroid.
Physician consultationTraining & practice
- MBBSMaulana Azad Medical College, New Delhi
- MD MedicineAll India Institute of Medical Sciences, New Delhi · 2017–2020
- DM Medical OncologyAll India Institute of Medical Sciences, New Delhi · 2021–2024
- Consultant Medical OncologistMedanta Hospital, Noida · 2025 – present
Academic distinctions
A record of competitive excellence and academic contribution.
Research & teaching
Beyond qualifications: contribution to the field.
- Randomised, double-blind, placebo-controlled research on gabapentin for paclitaxel-induced neuropathy, published in Trials.
- Work spanning breast cancer, prostate cancer, lymphoma, transplant medicine, PARP inhibitors, immunotherapy and survivorship.
- Contributions to the Manual of Clinical Oncology, a testicular germ-cell tumour chapter, a national tuberculosis training module and a primary CNS lymphoma chapter.
- Experience coordinating multidisciplinary tumour boards and teaching undergraduate and postgraduate trainees.
- Academic interests in biostatistics, survival modelling, clinical communication and responsible use of automation and AI in medicine.
Areas of work
What people come in with
A new diagnosis
Biopsy reports that need interpreting, staging that needs completing, and a first conversation about what the options actually are.
Second opinions
A treatment plan from elsewhere, reviewed independently — including when the honest answer is that the original plan was right.
Treatment already underway
Side-effect management, dose decisions, blood count monitoring and the day-to-day questions that come up between hospital cycles.
Supportive and palliative care
Pain, nausea, appetite, breathlessness and fatigue treated as problems in their own right, at any stage of illness.
Follow-up and survivorship
Surveillance after treatment finishes — scans, markers and the long tail of questions that follow a cancer diagnosis.
Family conversations
Time set aside for the people making decisions on a patient’s behalf, which is often the part that gets rushed elsewhere.
Procedures
Done here, in the clinic
Performed at the clinic under local anaesthetic, usually from the back of the hip. It is used to diagnose blood cancers such as leukaemia, lymphoma and myeloma, to investigate unexplained low blood counts, and to check response to treatment.
The procedure itself takes around twenty minutes. You can eat beforehand, and you can go home the same day — though it helps to have someone with you.
A peripherally inserted central catheter is a soft, thin tube placed into a vein in the upper arm and threaded towards a large central vein. It spares the smaller veins of the hand and forearm during long courses of chemotherapy, and allows blood samples to be taken without repeated needle pricks.
We insert and maintain PICC lines here and will teach the family how to look after the line at home.
Sampling of an accessible lump or lymph node — either a fine needle aspiration for cells or a core biopsy for a piece of tissue. Samples are sent for histopathology, and where required, for immunohistochemistry or molecular testing at accredited reference laboratories.
Drainage of fluid from the abdomen or the chest, both to relieve breathlessness or discomfort and to send fluid for analysis. Done at the clinic where the volume is modest and the patient is stable; where it is not, we will arrange it at hospital rather than attempt it here.
Regimen selection, dose calculation, pre-chemotherapy assessment and blood count monitoring happen at the clinic. Day-care chemotherapy infusions themselves are given at hospital, and we coordinate the scheduling so that you are not repeating consultations.
Germline and tumour genetic testing — including BRCA and other hereditary cancer panels — arranged through accredited laboratories, with the counselling that should accompany the result rather than a report handed over without explanation.
Publications & books
A research atlas—not a wall of citations.
Twenty-five listed works and four book contributions spanning breast cancer, genitourinary oncology, haematology and cell therapy, research methods, supportive care and emerging treatments.
Research is useful when it sharpens a decision at the bedside—not when it merely lengthens a résumé.
Explore by field
Publication library
Showing all 25 works
- Pandey P, Kumar A, Pushpam D, et al. Randomized double-blind, placebo-controlled study of oral gabapentin for prevention of neuropathy in patients receiving paclitaxel. Trials. 2023;24:79.
- Mendiratta M, Pandey P, et al. Predictive modeling of acute graft-versus-host disease using machine learning on immune-cell and cytokine profiles at engraftment. bioRxiv. 2025.
- Mendiratta M, Pandey P, et al. Machine learning algorithm-based prediction of acute graft-versus-host disease at engraftment through immune and cytokine profile. Transplantation scientific abstract.
- Clinical research publication in the Journal of the Practice of Cardiovascular Sciences. 2018;4(3):218–223.
- Clinical correlation of lung-ultrasound profiles in patients with COVID-19 infection. medRxiv. 2021.
- Pandey P, Sahoo RK. PARP inhibitors in metastatic prostate cancer: When, who, and how? Int J Mol Immuno Oncol. 2022;3:82–97.
- Pandey P, Sahoo RK. Myeloid neoplasms on poly (ADP-ribose) polymerase inhibitor therapy. Int J Mol Immuno Oncol. 2022;3:98–101.
- Pandey P, Sharma A, Gogia A. Bone health in breast cancer. Curr Probl Cancer. 2023;47:100959.
- Pandey P, Gogia A. Tisagenlecleucel in aggressive B-cell lymphoma. Cancer Res Stat Treat. 2022;5:394–395.
- Pandey P, Gogia A. Axicabtagene ciloleucel as second-line therapy for large B-cell lymphoma. Cancer Res Stat Treat. 2022;5:395.
- Pandey P, Gogia A. Polatuzumab vedotin in previously untreated diffuse large B-cell lymphoma. Cancer Res Stat Treat. 2022;5:350.
- Pandey P, Gogia A. Sequencing therapies for metastatic hormone receptor-positive breast cancer. Cancer Res Stat Treat. 2023;6:639.
- Pandey P, Gogia A. Sacituzumab govitecan: A narrative drug review. Cancer Res Stat Treat. 2023;6:562–572.
- Pandey P, Gogia A. Venetoclax in chronic lymphocytic leukemia. Cancer Res Stat Treat. 2023;6:638.
- Pandey P, Gogia A. Cabozantinib plus nivolumab and ipilimumab in renal-cell carcinoma. Cancer Res Stat Treat. 2023;6:635.
- Pandey P, Gogia A. Protocol amendment in clinical trials. Cancer Res Stat Treat. 2023;6:645.
- Pandey P, Gogia A. Time to question extended adjuvant endocrine therapy for all. Cancer Res Stat Treat. 2023;6:636–637.
- Pandey P, Gogia A. Fifteen-year outcomes in prostate cancer. Cancer Res Stat Treat. 2023;6:635–636.
- Pandey P, Gogia A. Anthracycline- and taxane-containing chemotherapy for early-stage breast cancer. Cancer Res Stat Treat. 2023;6:633–634.
- Pandey P, Gogia A. Empowering breast-cancer survivors: Nurturing self-compassion for a positive body image. Cancer Res Stat Treat. 2023;6:581–583.
- Pandey P, Gogia A. Rucaparib in metastatic prostate cancer. Cancer Res Stat Treat. 2023;6:360–361.
- Pandey P, Gogia A. Neoadjuvant pembrolizumab in advanced melanoma. Cancer Res Stat Treat. 2023;6:360.
- Mallick S, Pandey P, Gogia A. Breast-conserving surgery without irradiation in early breast cancer. Cancer Res Stat Treat. 2023;6:361–362.
- Pandey P, Gogia A. Ibrutinib plus bendamustine and rituximab in untreated mantle-cell lymphoma. Cancer Res Stat Treat. 2022;5:622.
- Advancements and perspectives of neoadjuvant immunotherapy in resectable non-small-cell lung cancer. Academic manuscript.
Book contribution
Management of testicular germ-cell tumours
Chapter authored with Dr. Ranjit Kumar Sahoo.
Clinical oncology
Manual of Clinical Oncology
Wrote and edited multiple chapters in the South-East Asian edition.
National training module
Extrapulmonary tuberculosis
Bone-tuberculosis module, 2023, with Dr. Umang Arora.
Lymphoma
Primary central nervous system lymphoma
Academic chapter focused on the Indian perspective.
Appointments
Begin with a plan you can understand and trust.
WhatsApp is the fastest way to reach us — send your name and what the appointment is for, and someone from the clinic will confirm a time.
